tiprankstipranks
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market

Chimeric Therapeutics Ltd. (CHM) Income Statement

1 Followers

Chimeric Therapeutics Ltd. Income Statement

Last quarter (Q4 2022), Chimeric Therapeutics Ltd.'s total revenue was AU$―. In Q4, Chimeric Therapeutics Ltd.'s net income was AU$―. See Chimeric Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21
Total Revenue
AU$ ―-AU$ 2.65K
Cost of Revenue
AU$ ―--
Gross Profit
AU$ ―-AU$ 2.65K
Operating Expense
AU$ ―AU$ 17.19MAU$ 14.85M
Operating Income
AU$ ―AU$ -17.19MAU$ -14.85M
Net Non Operating Interest Income Expense
AU$ ―AU$ -627.15KAU$ -3.23K
Other Income Expense
AU$ ―AU$ 2.08MAU$ -263.79K
Pretax Income
AU$ ―AU$ -15.73MAU$ -15.11M
Tax Provision
AU$ ―AU$ 163.72KAU$ 0.00
Earnings From Equity Interest Net Of Tax
AU$ ―--
Net Income Common Stockholders
AU$ ―AU$ -15.90MAU$ -15.11M
Basic EPS
AU$ ―AU$ -0.04AU$ -0.08
Diluted EPS
AU$ ―AU$ -0.04AU$ -0.08
Basic Average Shares
AU$ ―AU$ 359.93MAU$ 188.72M
Diluted Average Shares
AU$ ―AU$ 359.93MAU$ 188.72M
Dividend Per Share
AU$ ―--
Total Operating Income As Reported
AU$ ―--
Reported Normalized Basic E P S
AU$ ―--
Reported Normalized Diluted E P S
AU$ ―--
Rent Expense Supplemental
AU$ ―--
Total Expenses
AU$ ―--
Net Income From Continuing And Discontinued Operation
AU$ ―AU$ -15.90MAU$ -15.11M
Normalized Income
AU$ ―AU$ -15.90MAU$ -15.11M
Interest Expense
AU$ ―AU$ 640.13KAU$ 5.88K
EBIT
AU$ ―AU$ -15.09MAU$ -15.11M
EBITDA
AU$ ―AU$ -14.14MAU$ -15.11M
Currency in AUD

Chimeric Therapeutics Ltd. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis